KIR3DL1 and COVID-19: Future mechanistic studies are warranted to confirm the molecular basis of the decreased KIR3DL1+HLA-Bw4+ and KIR3DL2+HLA-A3/11+ gene combinations in dampening the effector functions of NK cells in COVID-19 patients.